Advertisement

Topics

Madison Vaccines Announces First Patient Dosed in an Expanded Combination Trial of MVI-816 Plus ...

05:06 EDT 2 Aug 2017 | BioMedReports - Blog
Corporate:
Madison Vaccines Incorporated
Richard Lesniewski, PhD, 610-850-4697
President
or
Media:
Initiate PR
Deanne Eagles, 917-837-5866
Deanne.eagle@initiatePR.com

Read more...

Original Article: Madison Vaccines Announces First Patient Dosed in an Expanded Combination Trial of MVI-816 Plus ...

NEXT ARTICLE

More From BioPortfolio on "Madison Vaccines Announces First Patient Dosed in an Expanded Combination Trial of MVI-816 Plus ..."

Quick Search
Advertisement